Die Statistik zeigt die Entwicklung des weltweiten Pharmaumsatzes in der Therapieklasse Antihypertonika (Mittel gegen Bluthochdruck) in den Jahren von 2012 bis 2019. Im Jahr 2019 belief sich laut dem
The data are results obtained from the in-vitro and in-vivo toxicological studies conducted for the safety evaluation of novel anti-hypertensive small molecule KSD179019. The in-vitro study includes M
Introduction: The potential risks related to drug exposure during pregnancy represent a vast chapter in modern obstetrics and data regarding the safety of antihypertensive drugs during pregnancy are r
In order to reveal the potential molecular mechanism of TDC in renal protection of rats with essential hypertension, TMT-based quantitative proteomics analysis method was used to conduct quantitative
